These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9250549)

  • 1. A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom.
    García Rodríguez LA; Ruigómez A; Jick H
    Pharmacotherapy; 1997; 17(4):721-8. PubMed ID: 9250549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs.
    García Rodríguez LA; Wallander MA; Stricker BH
    Br J Clin Pharmacol; 1997 Feb; 43(2):183-8. PubMed ID: 9131951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs.
    Pérez Gutthann S; García Rodríguez LA
    Epidemiology; 1993 Nov; 4(6):496-501. PubMed ID: 8268277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.
    García Rodríguez LA; Stricker BH; Zimmerman HJ
    Arch Intern Med; 1996 Jun; 156(12):1327-32. PubMed ID: 8651842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug- and herb-induced liver injury: a case series from a single center.
    Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A
    Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
    Lapeyre-Mestre M; de Castro AM; Bareille MP; Del Pozo JG; Requejo AA; Arias LM; Montastruc JL; Carvajal A
    Fundam Clin Pharmacol; 2006 Aug; 20(4):391-5. PubMed ID: 16867024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
    Sturkenboom M; Nicolosi A; Cantarutti L; Mannino S; Picelli G; Scamarcia A; Giaquinto C;
    Pediatrics; 2005 Jul; 116(1):e26-33. PubMed ID: 15930187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver damage -- a three-year study of patients from one gastroenterological department.
    Hartleb M; Biernat L; Kochel A
    Med Sci Monit; 2002 Apr; 8(4):CR292-6. PubMed ID: 11951073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced liver injury due to antimicrobials, central nervous system agents, and nonsteroidal anti-inflammatory drugs.
    Devarbhavi H; Andrade RJ
    Semin Liver Dis; 2014 May; 34(2):145-61. PubMed ID: 24879980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of amoxicillin and amoxicillin-clavulanic acid and hospitalization for acute liver injury.
    Maggini M; Raschetti R; Agostinis L; Cattaruzzi C; Troncon MG; Simon G
    Ann Ist Super Sanita; 1999; 35(3):429-33. PubMed ID: 10721209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs.
    Hernández-Díaz S; García-Rodríguez LA
    Am J Med; 2001 Feb; 110 Suppl 3A():20S-7S. PubMed ID: 11173046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of non-steroidal anti-inflammatory drugs in acute liver injury.
    García Rodríguez LA; Pérez Gutthann S; Walker AM; Lueck L
    BMJ; 1992 Oct; 305(6858):865-8. PubMed ID: 1422399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study.
    Kaye JA; Castellsague J; Bui CL; Calingaert B; McQuay LJ; Riera-Guardia N; Saltus CW; Quinlan S; Holick CN; Wahl PM; Suzart K; Rothman KJ; Wallander MA; Perez-Gutthann S
    Pharmacotherapy; 2014; 34(4):336-49. PubMed ID: 24865821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of epidemiologic studies in determining the true incidence of adverse events. The nonsteroidal anti-inflammatory drug story.
    Miwa LJ; Jones JK; Pathiyal A; Hatoum H
    Arch Intern Med; 1997 Oct; 157(18):2129-36. PubMed ID: 9382670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
    Walker AM
    Arthritis Rheum; 1997 Feb; 40(2):201-8. PubMed ID: 9041931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors.
    García Rodríguez LA; Williams R; Derby LE; Dean AD; Jick H
    Arch Intern Med; 1994 Feb; 154(3):311-6. PubMed ID: 8297198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should acute hepatic drug effects be studied epidemiologically?
    Guess HA
    Epidemiology; 1993 Nov; 4(6):487-9. PubMed ID: 8268274
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute and clinically relevant drug-induced liver injury: a population based case-control study.
    de Abajo FJ; Montero D; Madurga M; García Rodríguez LA
    Br J Clin Pharmacol; 2004 Jul; 58(1):71-80. PubMed ID: 15206996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver disorders in patients receiving chlorpromazine or isoniazid.
    Derby LE; Gutthann SP; Jick H; Dean AD
    Pharmacotherapy; 1993; 13(4):353-8. PubMed ID: 8361861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.